Alphabet Inc. is introducing AlphaGenome, an AI model aiding in DNA understanding and genetic impact analysis. This tool predicts genetic effects, assists in synthetic DNA design, and enhances genome comprehension. Available for non-commercial research, it aims to advance disease understanding and treatments.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing